Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 13.01% vs 6.20% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 57.52% vs -97.03% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 5.37% vs 14.77% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -14.54% vs -34.56% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Strides Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -4.39% vs 10.78% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 13.01% vs 6.20% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 23.61% vs -37.19% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 57.52% vs -97.03% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -4.14% vs 1.59% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 5.37% vs 14.77% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is -2.45% vs -4.15% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -14.54% vs -34.56% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






